Weight of Clinical and Social Determinants of Metabolic Syndrome in People Living with HIV
Author:
Mazzitelli MariaORCID, Fusco PaoloORCID, Brogna Michele, Vallone Alfredo, D’Argenio Laura, Beradelli Giuseppina, Foti Giuseppe, Mangano Carmelo, Carpentieri Maria, Cosco Lucio, Scerbo Paolo, Priamo Armando, Serrao Nicola, Mastroianni AntonioORCID, Costa Chiara, Tassone Maria, Scaglione VincenzoORCID, Serapide Francesca, Trecarichi EnricoORCID, Torti CarloORCID
Abstract
Background. Comorbidities in people living with HIV (PLWH) represent a major clinical challenge today, and metabolic syndrome (MTBS) is one of the most important. Objective. Our objective was to assess the prevalence of MTBS and the role of both clinical/socio-behavioral risk factors for MTBS in a cohort of PLWH. Methods. All PLWH, over 18 years of age, attending all Infectious Disease Units in Calabria Region (Southern Italy) for their routine checks from October 2019–January 2020 were enrolled. MTBS was defined by NCEP-ATP III criteria. Logistic regression analysis was performed to assess factors significantly associated with the main outcome (MTBS). Results. We enrolled 356 PLWH, mostly males (68.5%), with a mean age of 49 years (standard deviation: 12), including 98 subjects with and 258 without MTBS. At logistic regression analysis, a statistically significant association was found between MTBS and alcohol use, osteoporosis, polypharmacy, and a history of AIDS. Conclusions. Identifying and addressing risk factors, including those that are socio-behavioral or lifestyle-related, is crucial to prevent and treat MTBS. Our results suggest the importance of implementing educational/multidimensional interventions to prevent MTBS in PLWH, especially for those with particular risk factors (alcohol abuse, osteoporosis, previous AIDS events, and polypharmacy). Moreover, alcohol consumption or abuse should be routinely investigated in clinical practice.
Subject
Virology,Infectious Diseases
Reference39 articles.
1. The End of AIDS: HIV Infection as a Chronic Disease;Deeks;Lancet,2013 2. Bonnet, F., Le Marec, F., Leleux, O., Gerard, Y., Neau, D., Lazaro, E., Duffau, P., Caubet, O., Vandenhende, M.A., and Mercie, P. (2020). Evolution of comorbidities in people living with HIV between 2004 and 2014: Cross-sectional analyses from ANRS CO3 Aquitaine cohort. BMC Infect. Dis., 20. 3. Touloumi, G., Kalpourtzi, N., Papastamopoulos, V., Paparizos, V., Adamis, G., Antoniadou, A., Chini, M., Karakosta, A., Makrilakis, K., and Gavana, M. (2020). Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece. PLoS ONE, 15. 4. Excess cancers among HIV-infected people in the United States;Robbins;J. Natl. Cancer Inst.,2015 5. The metabolic syndrome and HIV infection;Maggi;Curr. Pharm. Des.,2014
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|